CBUS logo

CBUS Cibus, Inc.

NASDAQ · Biotechnology · Healthcare

$1.13
+0.04 (+3.67%)

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-thr…

Market Cap: $86.36Mwww.cibus.com

Price

No data yet.

Social Signal Score

50
5d
—
30d
—
60d
50
1 mentions
—
90d
50
1 mentions
—
news: 1

Analyst Ratings

4 analysts
Buyconsensus
Strong Buy 0Buy 3Hold 1Sell 0Strong Sell 0
Avg price target$11.5+917.7%
Low $10.5Median $11.5High $12.5
Current Consensus

Revenue

$800.0K+1011.11%
$2.0K$4.64M$9.28M$13.93M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$-2.31
$-2.38–$-2.24
1 analysts
FY2026
$-0.90
$-1.11–$-0.73
1 analysts
FY2027
$-0.68
$-0.84–$-0.55
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Craig Wichner
Sector
Healthcare
Industry
Biotechnology
Employees
118
Beta
1.57
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
-4.76
www.cibus.com